Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011)

Vanda Pharmaceuticals (VNDA) reported Change in Taxes of -$2.1 million for Q4 2011, down 417.95% on a YoY basis from $663000.0 in Q4 2010, and down 1765.49% sequentially from -$113000.0 in Q3 2011.

Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011) Analysis & Trends

Vanda Pharmaceuticals (VNDA) has 2 years of Change in Taxes data on file, last reported at -$2.1 million in Q4 2011.

  • For the quarter ending Q4 2011, Change in Taxes fell 417.95% year-over-year to -$2.1 million; the trailing twelve-month figure through Dec 2011 stood at -$2.3 million (changed N/A YoY), and the FY2011 full-year result was -$2.3 million, down 158.13% from the prior year.
  • Change in Taxes fell to -$2.1 million in Q4 2011, from -$113000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $663000.0 in Q4 2010 to a low of -$2.5 million in Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vanda Pharmaceuticals 318.71 Mn 116.40 Mn 48.56 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 -2.11 Mn
Dec 31, 2011 -2.11 Mn
Sep 30, 2011 -113,000.00
Sep 30, 2011 -113,000.00
Jun 30, 2011 -51,000.00
Jun 30, 2011 -51,000.00
Mar 31, 2011 6,000.00
Mar 31, 2011 6,000.00
Dec 31, 2010 663,000.00
Dec 31, 2010 663,000.00
Sep 30, 2010 -2.53 Mn
Sep 30, 2010 -2.53 Mn